Cost-benefit analysis of preventing nosocomial bloodstream infections among hemodialysis patients in Canada in 2004

Hong, Zhiyong, Wu, Jun, Tisdell, Clem, O'Leary, Crystal, Gomes, James, Wen, Shi-Wu and Njoo, Howard (2010) Cost-benefit analysis of preventing nosocomial bloodstream infections among hemodialysis patients in Canada in 2004. Value in Health, 13 1: 42-45. doi:10.1111/j.1524-4733.2009.00578.x

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Hong, Zhiyong
Wu, Jun
Tisdell, Clem
O'Leary, Crystal
Gomes, James
Wen, Shi-Wu
Njoo, Howard
Title Cost-benefit analysis of preventing nosocomial bloodstream infections among hemodialysis patients in Canada in 2004
Journal name Value in Health   Check publisher's open access policy
ISSN 1098-3015
1524-4733
Publication date 2010-01
Sub-type Article (original research)
DOI 10.1111/j.1524-4733.2009.00578.x
Open Access Status
Volume 13
Issue 1
Start page 42
End page 45
Total pages 4
Place of publication Malden, MA, United States
Publisher Blackwell Science
Collection year 2011
Language eng
Subject C1
Formatted abstract
Objectives: 
Hemodialysis-associated bloodstream infection (BSI) is a significant public health problem because the number of hemodialysis patients in Canada had doubled from 1996 to 2005.Our study aimed to determine the costs of nosocomial BSIs in Canada and estimate the investment expenses for establishing infection control programs in general hospitals and conduct cost–benefit analysis.

Materials and Methods:
The data from the Canadian Nosocomial Infection Surveillance Program was used to estimate the incidence rate of nosocomial BSI. We used Canadian Institute of Health Information data to estimate the extra costs of BSIs per stay across Canada in 2004. The cost of establishing and maintaining an infection control program in 1985 was estimated by the US Centers for Disease Control and Prevention and converted into 2004 Canadian costs. The possible 20% to 30% reduction of total nosocomial BSIs was hypothesized.

Results:
A total of 2524 hemodialysis-associated BSIs were projected among 15,278 hemodialysis patients in Canada in 2004. The total annual costs to treat BSIs were estimated to be CDN$49.01 million. Total investment costs in prevention and human resources were CDN$8.15 million. The savings of avoidable medical costs after establishing infection control programs were CDN$14.52 million. The benefit/cost ratio was 1.0 to 1.8:1.

Conclusion:
Our study provides evidence that the economic benefit from implementing infection control programs could be expected to be well in excess of additional cost postinfection if the reduction of BSI can be reduced by 20% to 30%. Infection control offered double benefits: saving money while simultaneously improving the quality of care.
Copyright © 2010 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Published by Elsevier Inc.

Keyword Bloodstream infection
Costs and benefits
Health economics
Infection control program
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Published January-February 2010.

Document type: Journal Article
Sub-type: Article (original research)
Collections: 2010 Higher Education Research Data Collection
School of Economics Publications
Ecology Centre Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 4 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 24 Jan 2010, 00:00:09 EST